These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31043584)

  • 81. SIRT1 inhibits mitochondrial hyperfusion associated mito-bulb formation to sensitize oral cancer cells for apoptosis in a mtROS-dependent signalling pathway.
    Patra S; Singh A; Praharaj PP; Mohanta NK; Jena M; Patro BS; Abusharha A; Patil S; Bhutia SK
    Cell Death Dis; 2023 Nov; 14(11):732. PubMed ID: 37949849
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex.
    Rasti G; Becker M; Vazquez BN; Espinosa-Alcantud M; Fernández-Duran I; Gámez-García A; Ianni A; Gonzalez J; Bosch-Presegué L; Marazuela-Duque A; Guitart-Solanes A; Segura-Bayona S; Bech-Serra JJ; Scher M; Serrano L; Shankavaram U; Erdjument-Bromage H; Tempst P; Reinberg D; Olivella M; Stracker TH; de la Torre C; Vaquero A
    Nucleic Acids Res; 2023 Jul; 51(13):6754-6769. PubMed ID: 37309898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of mitomycin C on X-ray repair cross complementing group 1 expression and consequent cytotoxicity regulation in human gastric cancer cells.
    Tung SY; Lin CT; Chen CN; Huang WS
    J Cell Biochem; 2019 May; 120(5):8333-8342. PubMed ID: 30614038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Accelerating cancer evolution: a dark side of SIRT1 in genome maintenance.
    Chen W
    Oncotarget; 2012 Apr; 3(4):363-4. PubMed ID: 22622047
    [No Abstract]   [Full Text] [Related]  

  • 85. Role of SIRT1 in Chemoresistant Leukemia.
    Fajardo-Orduña GR; Ledesma-Martínez E; Aguiñiga-Sanchez I; Weiss-Steider B; Santiago-Osorio E
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833921
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology.
    Bleker de Oliveira M; Koshkin V; Liu G; Krylov SN
    Anal Chem; 2020 Sep; 92(18):12101-12110. PubMed ID: 32790291
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance.
    Xu J; Shi Q; Xu W; Zhou Q; Shi R; Ma Y; Chen D; Zhu L; Feng L; Cheng AS; Morrison H; Wang X; Jin H
    Theranostics; 2019; 9(10):2999-3013. PubMed ID: 31244938
    [No Abstract]   [Full Text] [Related]  

  • 88. β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer.
    Song P; Feng L; Li J; Dai D; Zhu L; Wang C; Li J; Li L; Zhou Q; Shi R; Wang X; Jin H
    Mol Cancer; 2020 Aug; 19(1):129. PubMed ID: 32838807
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.
    Zhu L; Zhu Y; Han S; Chen M; Song P; Dai D; Xu W; Jiang T; Feng L; Shin VY; Wang X; Jin H
    Cell Death Dis; 2019 May; 10(6):383. PubMed ID: 31097692
    [TBL] [Abstract][Full Text] [Related]  

  • 90. EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer.
    Yang L; Ying S; Hu S; Zhao X; Li M; Chen M; Zhu Y; Song P; Zhu L; Jiang T; An H; Yousafzai NA; Xu W; Zhang Z; Wang X; Feng L; Jin H
    Signal Transduct Target Ther; 2019; 4():25. PubMed ID: 31637005
    [TBL] [Abstract][Full Text] [Related]  

  • 91. FGF21 promotes non-small cell lung cancer progression by SIRT1/PI3K/AKT signaling.
    Yu X; Li Y; Jiang G; Fang J; You Z; Shao G; Zhang Z; Jiao A; Peng X
    Life Sci; 2021 Mar; 269():118875. PubMed ID: 33310036
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
    Alves-Fernandes DK; Jasiulionis MG
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells.
    Zhang N; Nan A; Chen L; Li X; Jia Y; Qiu M; Dai X; Zhou H; Zhu J; Zhang H; Jiang Y
    Mol Cancer; 2020 Jun; 19(1):101. PubMed ID: 32493389
    [TBL] [Abstract][Full Text] [Related]  

  • 94. SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF.
    Kumari P; Tarighi S; Fuchshuber E; Li L; Fernández-Duran I; Wang M; Ayoson J; Castelló-García JM; Gámez-García A; Espinosa-Alcantud M; Sreenivasan K; Guenther S; Olivella M; Savai R; Yue S; Vaquero A; Braun T; Ianni A
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2409269121. PubMed ID: 38870055
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines.
    Escalante PI; Quiñones LA; Contreras HR
    Front Pharmacol; 2024; 15():1376638. PubMed ID: 38659583
    [No Abstract]   [Full Text] [Related]  

  • 96. Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer.
    Yousafzai NA; El Khalki L; Wang W; Szpendyk J; Sossey-Alaoui K
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473244
    [TBL] [Abstract][Full Text] [Related]  

  • 97. SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas.
    Białopiotrowicz-Data E; Noyszewska-Kania M; Jabłońska E; Sewastianik T; Komar D; Dębek S; Garbicz F; Wojtas M; Szydłowski M; Polak A; Górniak P; Juszczyński P
    Cell Death Dis; 2023 Oct; 14(10):667. PubMed ID: 37816710
    [TBL] [Abstract][Full Text] [Related]  

  • 98. DNA Damage-Mediated Neurotoxicity in Parkinson's Disease.
    Wang ZX; Li YL; Pu JL; Zhang BR
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047285
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efficient prioritization of CRISPR screen hits by accounting for targeting efficiency of guide RNA.
    Park BS; Jeon H; Chi SG; Kim T
    BMC Biol; 2023 Feb; 21(1):45. PubMed ID: 36829149
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeting the DNA Damage Response Machinery for Lung Cancer Treatment.
    Venugopala KN
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.